Results 81 to 90 of about 8,505 (243)
Classic psychedelics, including psilocybin, lysergic acid diethylamide (LSD), dimethyltryptamine, and mescaline, and entactogens/empathogens, especially 3,4-methylenedioxymethamphetamine, have received renewed attention in psychiatric research and may be
Friederike Holze +3 more
core +1 more source
Abstract Background and Objectives Readmission to residential treatment increases healthcare costs, strains publicly funded systems, and may not adequately meet clients' needs. This study examined rates and predictors of readmission to residential treatment among clients transitioned from detoxification services.
Abreham Mekonnen
wiley +1 more source
The Birth of the Psychedelic Industry: Capitalizing on the Psychedelic Renaissance
ABSTRACTThe resurgence of psychedelic medicine, often termed ‘the psychedelic renaissance,’ marks a profound shift from decades of repressed research to a burgeoning field characterised by significant scientific, regulatory, and economic transformations. Once marginalised, psychedelics are now experiencing widespread interest and investment, spurred by
Minsu Yoo, Sofia Sakopoulos
openaire +1 more source
On 3‐MMC: A Cathinone I Have Come to Know and Love
ABSTRACT This article attempts to complicate the mythology of a compound in a state of becoming. I will trace lightly its origins as a cultural disruptor and how I am implicated in this imperative. Introducing you to 3‐MMC will require multiple modes of storytelling and taking of liberties, drawing on literature reviews, practice‐based research, prose,
Carmen Ostrander
wiley +1 more source
Psychedelic medicine: The biology underlying the persisting psychedelic effects
Psychedelic substances have regained interest as therapeutic agents in the treatment of stress-related disorders. The effects seem to be of persisting nature even after a single dose. Also in lower than 'regular' recreational doses, so-called micro-doses, without the typical effects on consciousness, users report beneficial effects on cognitive ...
openaire +3 more sources
Psychedelic unselfing: self-transcendence and change of values in psychedelic experiences
Psychedelic experiences have been shown to both facilitate (re)connection to one’s values and change values, including enhancing aesthetic appreciation, promoting pro-environmental attitudes, and encouraging prosocial behavior. This article presents an empirically informed framework of philosophical psychology to understand how self-transcendence ...
openaire +4 more sources
Endorsement of metaphysical idealism mediates a link between past use of psychedelics and wellbeing
It has been proposed that psychedelics promote wellbeing through spiritual-type transformations, involving changes in metaphysical beliefs. Past empirical research shows a link between the use of psychedelics and the endorsement of non-physicalist ...
Jussi Jylkkä +2 more
doaj +1 more source
(Un)threading Rhythms: On Affect and Vibe in a Rave
ABSTRACT In Toronto, raves arise across large nightclubs, DIY venues and outdoors, despite changing regulations that have further arranged and narrowed their possibility in the past 4 years. Following a rave in Toronto, this work explores ways that potentialities and affects emerge in a single night, through my entry of taking part in dancing and ...
Tatiana Yunadi
wiley +1 more source
Unlocking Psychedelics’ Medical Potential
“I am he as you are he as you are me and we are all together,” John Lennon sang in 1967. The lyrics—which Lennon wrote on an acid trip—express the mystical dissolution of self that users of psychedelic drugs often experience.
Jacobs, Peter +2 more
core +1 more source
Safety pharmacology of acute mescaline administration in healthy participants
Aims Psychedelics, including mescaline, may serve as novel treatments for depression and anxiety. However, data is scarce on the safety of mescaline. Methods The present pooled analysis included two double‐blind, randomized, placebo‐controlled studies with a total of 48 participants and 96 mescaline administrations. Single oral‐dose administrations (n =
Aaron Klaiber +4 more
wiley +1 more source

